Patents by Inventor Mariola Mann

Mariola Mann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL PROPELLANT CONTAINING PREPARATIONS FOR TIOTROPIUM
    Publication number: 20170367971
    Abstract: The present invention relates to a novel propellant-gas-containing medicament composition based on tiotropium 1, processes for the preparation thereof and the use of such medicament compositions in the treatment of respiratory complaints.
    Type: Application
    Filed: September 8, 2017
    Publication date: December 28, 2017
    Inventors: Bettina BERNER, Hubert HOELZ, Mariola MANN
  • NOVEL PROPELLANT CONTAINING PREPARATIONS FOR TIOTROPIUM
    Publication number: 20160106664
    Abstract: The present invention relates to a novel propellant-gas-containing medicament composition based on tiotropium 1, processes for the preparation thereof and the use of such medicament compositions in the treatment of respiratory complaints.
    Type: Application
    Filed: December 29, 2015
    Publication date: April 21, 2016
    Inventors: Bettina Berner, Hubert Hoelz, Mariola Mann
  • NOVEL PROPELLANT CONTAINING PREPARATIONS FOR TIOTROPIUM
    Publication number: 20150258024
    Abstract: The present invention relates to a novel propellant-gas-containing medicament composition based on tiotropium 1, processes for the preparation thereof and the use of such medicament compositions in the treatment of respiratory complaints.
    Type: Application
    Filed: June 2, 2015
    Publication date: September 17, 2015
    Inventors: Bettina BERNER, Hubert HOELZ, Mariola MANN
  • NOVEL PROPELLANT CONTAINING PREPARATIONS FOR TIOTROPIUM
    Publication number: 20130302260
    Abstract: The present invention relates to a novel propellant-gas-containing medicament composition based on tiotropium 1, processes for the preparation thereof and the use of such medicament compositions in the treatment of respiratory complaints.
    Type: Application
    Filed: February 28, 2013
    Publication date: November 14, 2013
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Bettina BERNER, Hubert HOELZ, Mariola MANN
  • Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant
    Patent number: 8518377
    Abstract: The invention relates to pressurized gas formulations for dosage aerosols, in which a medicament is formulated suspended in TG 227 ea (1,1,1,2,3,3,3-heptafluoropropane) and/or TG 134 a (1,1,1,2-tetrafluoroethane) as a propellant, and to their use for producing a medicament. The aerosol is preferably an inhalation aerosol.
    Type: Grant
    Filed: April 4, 2007
    Date of Patent: August 27, 2013
    Assignee: Boehringer Ingelheim Pharma GbmH Co. KG
    Inventors: Hubert Hoelz, Mariola Mann, Christel Schmelzer, Friedrich Schmidt, Hans-Hermann Weil
  • Aerosol suspension formulations with TG 227 ea or TG 134 a as propellant
    Publication number: 20090092559
    Abstract: The invention relates to pressurized gas formulations for dosage aerosols, in which a medicament is formulated suspended in TG 227 ea (1,1,1,2,3,3,3-heptafluoropropane) and/or TG 134 a (1,1,1,2-tetrafluoroethane) as a propellant, and to their use for producing a medicament. The aerosol is preferably an inhalation aerosol.
    Type: Application
    Filed: April 4, 2007
    Publication date: April 9, 2009
    Applicant: BOEHRINGER INGELHEIM PHARMA GBMH CO. KG
    Inventors: Hubert Hoelz, Mariola Mann, Christel Schmelzer, Friedrich Schmidt, Hans-Hermann Weil
  • HFC SOLUTION FORMULATIONS CONTAINING SALBUTAMOL HYDROCHLORIDE OR SALBUTAMOL CITRATE
    Publication number: 20070041911
    Abstract: This invention relates to stabilized aerosol solution formulations containing acid addition salts of salbutamol, which are suitable for administration by metered dose inhalers (MDIs). More particularly, this invention relates to solution formulations containing one of the aforementioned salts of salbutamol, preferably salbutamol hydrochloride or salbutamol citrate, more preferably one of the two before mentioned salts in combination with one or more additional pharmacologically active substances, together with an environmentally safe hydrofluorocarbon (HFC) as a propellant, a co-solvent, preferably an organic compound as a co-solvent, and either an inorganic acid or an organic acid.
    Type: Application
    Filed: August 9, 2006
    Publication date: February 22, 2007
    Inventors: Friedrich Schmidt, Mariola Mann, Michael Cope, Holger Memmesheimer